Ireland - English - HPRA (Health Products Regulatory Authority)

mcdermott laboratories ltd t/a gerard laboratories - pemetrexed disodium - pdr/conc/soln for infus - 500 milligram(s) - antimetabolites

Ireland - English - HPRA (Health Products Regulatory Authority)

generics (uk) limited - pemetrexed disodium - pdr/conc/soln for infus - 500 milligram - antimetabolites

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - pemetrexed disodium, quantity: 110.28 mg (equivalent: pemetrexed, qty 100 mg) - injection, powder for - excipient ingredients: mannitol - malignant pleural mesothelioma,in combination with cisplatin, is indicated for the treatment of patients with malignant pleural mesothelioma.,non small cell lung cancer,in combination with cisplatin, is indicated for initial treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.,as monotherapy, is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology after prior platinum based chemotherapy.

Canada - English - Health Canada

apotex inc - pemetrexed (pemetrexed disodium) - powder for solution - 500mg - pemetrexed (pemetrexed disodium) 500mg - antineoplastic agents

Canada - English - Health Canada

apotex inc - pemetrexed (pemetrexed disodium) - powder for solution - 100mg - pemetrexed (pemetrexed disodium) 100mg - antineoplastic agents

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

seacross pharmaceuticals ltd - pemetrexed disodium - powder for solution for infusion - 100mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

seacross pharmaceuticals ltd - pemetrexed disodium - powder for solution for infusion - 500mg

Australia - English - Department of Health (Therapeutic Goods Administration)

medtas pty ltd - pemetrexed disodium, quantity: 551.5 mg - injection, powder for - excipient ingredients: mannitol - malignant pleural mesothelioma. pemetrexed, in combination with cisplatin, is indicated for the treatment of patients with malignant pleural mesothelioma.,non-small cell lung cancer. pemetrexed in combination with cisplatin is indicated for initial treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. pemetrexed as monotherapy is indicated for the treatment of patients with locally advanced or metastatic non-small-cell lung cancer other than predominantly squamous cell histology after prior platinum-based chemotherapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

medtas pty ltd - pemetrexed disodium, quantity: 110.3 mg - injection, powder for - excipient ingredients: mannitol - malignant pleural mesothelioma. pemetrexed, in combination with cisplatin, is indicated for the treatment of patients with malignant pleural mesothelioma.,non-small cell lung cancer. pemetrexed in combination with cisplatin is indicated for initial treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. pemetrexed as monotherapy is indicated for the treatment of patients with locally advanced or metastatic non-small-cell lung cancer other than predominantly squamous cell histology after prior platinum-based chemotherapy.

Canada - English - Health Canada

dr reddy's laboratories ltd - pemetrexed (pemetrexed disodium) - powder for solution - 100mg - pemetrexed (pemetrexed disodium) 100mg - antineoplastic agents